DK2515854T3 - Aerosolformulering for COPD - Google Patents

Aerosolformulering for COPD

Info

Publication number
DK2515854T3
DK2515854T3 DK10799029.3T DK10799029T DK2515854T3 DK 2515854 T3 DK2515854 T3 DK 2515854T3 DK 10799029 T DK10799029 T DK 10799029T DK 2515854 T3 DK2515854 T3 DK 2515854T3
Authority
DK
Denmark
Prior art keywords
copd
aerosol formulation
aerosol
formulation
Prior art date
Application number
DK10799029.3T
Other languages
English (en)
Inventor
Sauro Bonelli
Francesca Usberti
Enrico Zambelli
Original Assignee
Chiesi Farma Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=42046446&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK2515854(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Chiesi Farma Spa filed Critical Chiesi Farma Spa
Application granted granted Critical
Publication of DK2515854T3 publication Critical patent/DK2515854T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65B—MACHINES, APPARATUS OR DEVICES FOR, OR METHODS OF, PACKAGING ARTICLES OR MATERIALS; UNPACKING
    • B65B31/00—Packaging articles or materials under special atmospheric or gaseous conditions; Adding propellants to aerosol containers
    • B65B31/04—Evacuating, pressurising or gasifying filled containers or wrappers by means of nozzles through which air or other gas, e.g. an inert gas, is withdrawn or supplied
    • B65B31/06—Evacuating, pressurising or gasifying filled containers or wrappers by means of nozzles through which air or other gas, e.g. an inert gas, is withdrawn or supplied the nozzle being arranged for insertion into, and withdrawal from, the mouth of a filled container and operating in conjunction with means for sealing the container mouth
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65B—MACHINES, APPARATUS OR DEVICES FOR, OR METHODS OF, PACKAGING ARTICLES OR MATERIALS; UNPACKING
    • B65B31/00—Packaging articles or materials under special atmospheric or gaseous conditions; Adding propellants to aerosol containers
    • B65B31/10—Adding propellants in solid form to aerosol containers
DK10799029.3T 2009-12-23 2010-12-22 Aerosolformulering for COPD DK2515854T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP09015980 2009-12-23
PCT/EP2010/070478 WO2011076842A2 (en) 2009-12-23 2010-12-22 Aerosol formulation for copd

Publications (1)

Publication Number Publication Date
DK2515854T3 true DK2515854T3 (da) 2014-05-26

Family

ID=42046446

Family Applications (1)

Application Number Title Priority Date Filing Date
DK10799029.3T DK2515854T3 (da) 2009-12-23 2010-12-22 Aerosolformulering for COPD

Country Status (31)

Country Link
US (4) US20110150783A1 (da)
EP (1) EP2515854B1 (da)
JP (1) JP5800829B2 (da)
KR (1) KR101747474B1 (da)
CN (1) CN102665680B (da)
AU (2) AU2010334858A1 (da)
CA (1) CA2785317C (da)
CL (1) CL2012001668A1 (da)
CO (1) CO6551734A2 (da)
CY (1) CY1115109T1 (da)
DK (1) DK2515854T3 (da)
EA (1) EA021604B1 (da)
ES (1) ES2464520T3 (da)
GE (1) GEP20166479B (da)
HK (1) HK1174568A1 (da)
HR (1) HRP20140550T1 (da)
IL (1) IL220534A0 (da)
MA (1) MA33821B1 (da)
MX (1) MX340264B (da)
MY (1) MY156950A (da)
NZ (1) NZ600789A (da)
PE (1) PE20121467A1 (da)
PL (1) PL2515854T3 (da)
PT (1) PT2515854E (da)
RS (1) RS53355B (da)
SG (1) SG181870A1 (da)
SI (1) SI2515854T1 (da)
TN (1) TN2012000261A1 (da)
UA (1) UA106098C2 (da)
WO (1) WO2011076842A2 (da)
ZA (1) ZA201204613B (da)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102665678B (zh) * 2009-12-23 2014-07-02 奇斯药制品公司 用于copd的联合治疗
AR079726A1 (es) * 2009-12-23 2012-02-15 Chiesi Farma Spa Terapia combinada para enfermedad pulmonar obstructiva cronica (epoc) . composicion farmaceutica.frasco de aerosol. metodo.conjunto de componentes
UA106098C2 (uk) * 2009-12-23 2014-07-25 К'Єзі Фармачеутічі С.П.А. Аерозольна композиція для хозл
SG11201605311UA (en) * 2013-12-30 2016-07-28 Chiesi Farma Spa Stable pressurised aerosol solution composition of glycopyrronium bromide and formoterol combination
PE20161132A1 (es) * 2013-12-30 2016-11-02 Chiesi Farm Spa Composicion combinada de bromuro de glicopirronio y formoterol en solucion estable presurizada para aerosol
CN108289843B (zh) 2015-12-04 2021-08-17 墨西哥氟石股份公司 药物组合物
PE20191043A1 (es) * 2016-09-19 2019-08-06 Mexichem Fluor Sa De Cv Composicion farmaceutica
WO2020084549A1 (en) * 2018-10-25 2020-04-30 Glenmark Specialty S.A. Nebulization composition comprising glycopyrrolate and formoterol
AU2021314977A1 (en) 2020-07-31 2023-03-02 Chemo Research, S.L. Combination therapy for inhalation administration
CN112051346A (zh) * 2020-09-24 2020-12-08 珠海瑞思普利生物制药有限公司 一种同时测定茚达特罗和格隆溴铵含量的hplc方法
WO2022074183A1 (en) 2020-10-09 2022-04-14 Chiesi Farmaceutici S.P.A. A pharmaceutical formulation for pressurised metered dose inhaler
WO2023227781A1 (en) 2022-05-27 2023-11-30 Chiesi Farmaceutici S.P.A. A pharmaceutical formulation for pressurised metered dose inhaler

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2956062A (en) 1959-02-26 1960-10-11 Robins Co Inc A H Esters of amino alcohols
DE69324161T2 (de) 1992-12-09 1999-10-28 Boehringer Ingelheim Pharma Stabilisierte medizinische aerosollösungen
DK1102579T3 (da) 1998-08-04 2003-07-14 Jago Res Ag Medicinske aerosolformuleringer
IT1317720B1 (it) 2000-01-07 2003-07-15 Chiesi Farma Spa Dispositivo per la somministrazione di aerosol dosati pressurizzati inpropellenti idrofluoroalcani.
GB0008660D0 (en) 2000-04-07 2000-05-31 Arakis Ltd The treatment of respiratory diseases
US20060257324A1 (en) * 2000-05-22 2006-11-16 Chiesi Farmaceutici S.P.A. Pharmaceutical solution formulations for pressurised metered dose inhalers
BR0015884A (pt) * 2000-05-22 2003-07-08 Chiesi Farma Spa Formulações de soluções farmacêuticas estáveis para inaladores de dose medida pressurizados
ATE375142T1 (de) * 2001-03-30 2007-10-15 Jagotec Ag Medizinische aerosolformulierungen
US6667344B2 (en) 2001-04-17 2003-12-23 Dey, L.P. Bronchodilating compositions and methods
EP1321159A1 (en) 2001-12-21 2003-06-25 CHIESI FARMACEUTICI S.p.A. Pressurized metered dose inhaler (pMDI) actuators with laser drilled orifices
PT3384931T (pt) 2002-03-01 2019-09-26 Chiesi Farm Spa Formulaçâo superfina de formoterol
CN1726038A (zh) 2002-12-16 2006-01-25 贝林格尔英格海姆法玛两合公司 含有噻托铵的hfc溶液剂
EP1718336B1 (en) 2004-02-06 2008-06-25 MEDA Pharma GmbH & Co. KG Novel combination of anticholinergic and beta mimetics for the treatment of respiratory diseases
GB0410399D0 (en) 2004-05-10 2004-06-16 Arakis Ltd The treatment of respiratory disease
GB0613161D0 (en) * 2006-06-30 2006-08-09 Novartis Ag Organic Compounds
EP1894568A1 (en) 2006-08-31 2008-03-05 Novartis AG Pharmaceutical compositions for the treatment of inflammatory or obstructive airway diseases
AU2008314628B2 (en) 2007-10-18 2014-03-06 Rose U Topical glycopyrrolate formulations
AU2010258751A1 (en) * 2009-06-09 2012-02-02 Sunovion Respiratory Development Inc. Treatment of chronic obstructive pulmonary disease with nebulized beta 2-agonist or combined nebulized beta 2-agonist and anticholinergic administration
AR079726A1 (es) * 2009-12-23 2012-02-15 Chiesi Farma Spa Terapia combinada para enfermedad pulmonar obstructiva cronica (epoc) . composicion farmaceutica.frasco de aerosol. metodo.conjunto de componentes
CN102665678B (zh) * 2009-12-23 2014-07-02 奇斯药制品公司 用于copd的联合治疗
UA106098C2 (uk) * 2009-12-23 2014-07-25 К'Єзі Фармачеутічі С.П.А. Аерозольна композиція для хозл
KR20120106753A (ko) * 2009-12-23 2012-09-26 키에시 파르마슈티시 엣스. 피. 에이. Ｃｏｐｄ용 에어로졸 제제
BR112013002504A2 (pt) * 2010-08-03 2016-05-31 Chiesi Farma Spa formulação farmacêutica para administração em aerosol, inalador pressurizado dosimetrado (pmdi), formulação farmacêutica para nebulização, frasco de dose única ou múltiplas e uso de uma formulação
GB201200525D0 (en) 2011-12-19 2012-02-29 Teva Branded Pharmaceutical Prod R & D Inc An inhalable medicament
PE20161132A1 (es) 2013-12-30 2016-11-02 Chiesi Farm Spa Composicion combinada de bromuro de glicopirronio y formoterol en solucion estable presurizada para aerosol
SG11201605311UA (en) * 2013-12-30 2016-07-28 Chiesi Farma Spa Stable pressurised aerosol solution composition of glycopyrronium bromide and formoterol combination

Also Published As

Publication number Publication date
AU2010334858A1 (en) 2012-07-12
TN2012000261A1 (en) 2013-12-12
US20230157951A1 (en) 2023-05-25
CA2785317A1 (en) 2011-06-30
MY156950A (en) 2016-04-15
AU2016234894B2 (en) 2018-02-22
JP2013515695A (ja) 2013-05-09
JP5800829B2 (ja) 2015-10-28
EA201290374A1 (ru) 2013-01-30
US20210000738A1 (en) 2021-01-07
BR112012015336A2 (pt) 2016-03-15
US10806701B2 (en) 2020-10-20
MX340264B (es) 2016-07-04
GEP20166479B (en) 2016-05-25
NZ600789A (en) 2014-09-26
US11590074B2 (en) 2023-02-28
EA021604B1 (ru) 2015-07-30
CN102665680B (zh) 2014-07-30
CY1115109T1 (el) 2016-12-14
CL2012001668A1 (es) 2012-12-07
CA2785317C (en) 2018-02-27
WO2011076842A3 (en) 2011-12-01
MA33821B1 (fr) 2012-12-03
RS53355B (en) 2014-10-31
PT2515854E (pt) 2014-05-27
PL2515854T3 (pl) 2014-08-29
CN102665680A (zh) 2012-09-12
US20110150783A1 (en) 2011-06-23
ZA201204613B (en) 2013-09-25
ES2464520T3 (es) 2014-06-03
EP2515854A2 (en) 2012-10-31
HK1174568A1 (en) 2013-06-14
SI2515854T1 (sl) 2014-07-31
IL220534A0 (en) 2012-08-30
EP2515854B1 (en) 2014-03-19
KR20120120160A (ko) 2012-11-01
HRP20140550T1 (hr) 2014-07-18
UA106098C2 (uk) 2014-07-25
MX2012006879A (es) 2012-07-04
AU2016234894A1 (en) 2016-10-13
US20150306026A1 (en) 2015-10-29
CO6551734A2 (es) 2012-10-31
SG181870A1 (en) 2012-07-30
WO2011076842A2 (en) 2011-06-30
PE20121467A1 (es) 2012-11-07
KR101747474B1 (ko) 2017-06-14

Similar Documents

Publication Publication Date Title
CY2017047I2 (el) Συνδυαστικη θεραπεια για χαπ
DK2515854T3 (da) Aerosolformulering for COPD
LTPA2018516I1 (lt) Testosterono kompozicijos
IL219592A0 (en) Antibody formulation
ZA201106503B (en) Antibody formulation
ZA201203242B (en) Antibody formulation
BR112013004349A2 (pt) acionadores de aerossol
EP2581431A4 (en) AEROSOL COMPOSITION
DK2376334T3 (da) Pakke til tobaksrelaterede artikler
BR112013011042A2 (pt) dispensador
BRPI1009465A2 (pt) Formulação
ZA201208127B (en) Aerosol compositions
HK1174562A1 (en) Aerosol formulation for copd copd
PL2338587T3 (pl) Urządzenie do wytwarzania aerozolu
ITPD20090053U1 (it) Paradordi per banchine
BR112012019886A2 (pt) conjunto de dispensação
DK2598175T3 (da) Radiofarmaceutiske sammensætninger
ITVI20130259A1 (it) Composizione propellente liquefatta per aerosol
EE00860U1 (et) Soolaaerosooli kllastamisseade
TH1301000562B (th) ตัวขับสำหรับภาชนะบรรจุละอองลอย
UA19340S (uk) Упаковка для вермішелі
DE112010004213A5 (de) Faltschachtel
TH115086B (th) ชิ้นส่วนอุปกรณ์จ่ายยา
TH114462B (th) สารรวมสำหรับใช้กำจัดแมลง
ITCT20090003U1 (it) Telepass -2 per non udenti